Prestige Consumer Healthcare to Release Fiscal 2025 Second Quarter Earnings Results
Prestige Consumer Healthcare Inc. (NYSE:PBH) has announced the release date for its fiscal 2025 second quarter earnings. The company will issue the earnings release on Thursday, November 7, 2024, before the market opens. Following the release, Prestige Consumer Healthcare will host a conference call at 8:30 a.m. ET to discuss the results.
Investors and interested parties can participate in the earnings discussion through two methods:
- A live Internet webcast accessible from the Investor Relations page of www.prestigeconsumerhealthcare.com
- A conference call via phone, with registration required to receive dial-in details and a unique pin
Participants are advised to join 10 minutes prior to the event start. A replay of the conference call will be available for approximately one week on the company's Investor Relations page.
Prestige Consumer Healthcare Inc. (NYSE:PBH) ha annunciato la data di rilascio per i suoi risultati finanziari del secondo trimestre dell'esercizio 2025. L'azienda pubblicherà il comunicato sui risultati giovedì 7 novembre 2024, prima dell'apertura del mercato. Dopo il rilascio, Prestige Consumer Healthcare terrà una conference call alle 8:30 a.m. ET per discutere i risultati.
Gli investitori e le parti interessate possono partecipare alla discussione sui risultati attraverso due modalità:
- Un webcast dal vivo accessibile dalla pagina Relazioni con gli Investitori di www.prestigeconsumerhealthcare.com
- Una conference call tramite telefono, con registrazione richiesta per ricevere i dettagli di accesso e un pin unico
I partecipanti sono invitati a collegarsi 10 minuti prima dell'inizio dell'evento. Una registrazione della conference call sarà disponibile per circa una settimana sulla pagina Relazioni con gli Investitori dell'azienda.
Prestige Consumer Healthcare Inc. (NYSE:PBH) ha anunciado la fecha de publicación de sus resultados financieros del segundo trimestre del ejercicio 2025. La compañía emitirá el comunicado de resultados el jueves 7 de noviembre de 2024, antes de la apertura del mercado. Tras la publicación, Prestige Consumer Healthcare llevará a cabo una conferencia telefónica a las 8:30 a.m. ET para discutir los resultados.
Los inversores y partes interesadas pueden participar en la discusión de los resultados a través de dos métodos:
- Una transmisión en vivo accesible desde la página de Relaciones con Inversores de www.prestigeconsumerhealthcare.com
- Una conferencia telefónica por teléfono, con registro requerido para recibir detalles de acceso y un pin único
Se aconseja a los participantes unirse 10 minutos antes del inicio del evento. Una repetición de la conferencia telefónica estará disponible durante aproximadamente una semana en la página de Relaciones con Inversores de la compañía.
Prestige Consumer Healthcare Inc. (NYSE:PBH)는 2025 회계연도 2분기 실적 발표 날짜를 발표했습니다. 이 회사는 2024년 11월 7일 목요일에 시장 개장 전에 실적 발표를 할 예정입니다. 발표 후 Prestige Consumer Healthcare는 동부 표준시 8:30 a.m.에 결과를 논의하는 컨퍼런스 콜를 진행할 것입니다.
투자자 및 관심 있는 분들은 두 가지 방법으로 실적 논의에 참여할 수 있습니다:
- www.prestigeconsumerhealthcare.com의 투자자 관계 페이지에서 접근할 수 있는 라이브 인터넷 웹캐스트
- 전화 회의, 접속 정보와 고유 PIN을 받기 위해 등록이 필요합니다
참가자들은 이벤트 시작 10분 전에 접속하는 것이 좋습니다. 컨퍼런스 콜의 재생은 회사의 투자자 관계 페이지에서 약 1주일 동안 제공될 것입니다.
Prestige Consumer Healthcare Inc. (NYSE:PBH) a annoncé la date de publication de ses résultats du deuxième trimestre de l'exercice 2025. L'entreprise publiera le communiqué de résultats le jeudi 7 novembre 2024, avant l'ouverture du marché. Suite à cette publication, Prestige Consumer Healthcare animera une conférence téléphonique à 8h30 ET pour discuter des résultats.
Les investisseurs et les parties intéressées peuvent participer à la discussion des résultats de deux manières :
- Un webinaire en direct accessible depuis la page des Relations Investisseurs de www.prestigeconsumerhealthcare.com
- Une conférence téléphonique, avec une inscription requise pour recevoir les détails de connexion et un code PIN unique
Les participants sont conseillés de se joindre 10 minutes avant le début de l'événement. Un enregistrement de la conférence téléphonique sera disponible pendant environ une semaine sur la page des Relations Investisseurs de l'entreprise.
Prestige Consumer Healthcare Inc. (NYSE:PBH) hat das Veröffentlichungsdatum für seine Ergebnisse des zweiten Quartals des Geschäftsjahres 2025 bekanntgegeben. Das Unternehmen wird am Donnerstag, den 7. November 2024, vor Markteröffnung die Ergebnisse veröffentlichen. Nach der Veröffentlichung wird Prestige Consumer Healthcare eine Telefonkonferenz um 8:30 Uhr ET abhalten, um die Ergebnisse zu besprechen.
Investoren und interessierte Parteien können auf zwei Arten an der Ergebnissdiskussion teilnehmen:
- Ein Live-Internet-Webcast, der von der Investor-Relations-Seite von www.prestigeconsumerhealthcare.com zugänglich ist
- Eine Telefonkonferenz, für die eine Registrierung erforderlich ist, um die Einwahldaten und eine eindeutige PIN zu erhalten
Teilnehmer werden gebeten, sich 10 Minuten vor Beginn der Veranstaltung einzuwählen. Eine Wiederholung der Telefonkonferenz wird etwa eine Woche lang auf der Investor-Relations-Seite des Unternehmens verfügbar sein.
- None.
- None.
TARRYTOWN, N.Y., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 second quarter earnings release on Thursday, November 7, 2024 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.
A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
FAQ
When will Prestige Consumer Healthcare (PBH) release its fiscal 2025 Q2 earnings?
How can investors participate in Prestige Consumer Healthcare's (PBH) Q2 2025 earnings call?
What time is Prestige Consumer Healthcare's (PBH) fiscal 2025 Q2 earnings call scheduled for?
Will there be a replay available for Prestige Consumer Healthcare's (PBH) Q2 2025 earnings call?
